Understand health economic analyses

Learn, how you can put a value on quality of life

28 Nov 2022

1 day course

Danish

5,950 DKK ex VAT
(app. 800 EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Are you looking for a basic introduction to health economic analyses with special attention to the use of QALY (Quality-adjusted Life Years) as a cost effectiveness measure? This course provides you with a theoretical framework and real use cases.

In Denmark, The Danish Medicines Council started using QALY as a cost- effectiveness measure back in January 2021. What are the experiences to date using cost per QALY in the Danish Medicines Council?

This is a basic methodology course, where professionals working with market access for new, innovative medicines can get a deep dive into the use of health economic models as prioritisation tools.

Key words

  • Health economic models
  • QALY and ICER
  • Health economic analysis
  • Uncertainty
Read more

Course leader(s) & Lecturer(s)

  • Anne Kolbye
    Course leader
    Value Demonstration Manager
    Roche A/S
  • Signe Thybo
    Course leader
    Senior Manager, Nordic Value, HTA & HEOR
    Bristol-Myers Squibb
See all

IS THIS COURSE FOR YOU?

The course is especially relevant for Market Access Managers, Medical Affairs (Heads of, MSLs), Commercial (Business Unit Heads), and Product managers.

What you will learn

  1. What health economic analyses can be used for.
  2. Types of health economic models.
  3. What an ICER is.
  4. The concept of a QALY and how it is calculated.
  5. Managing uncertainty in health economic models.

What your company will get

  1. An employee who understands the rationale behind using health economic analyses.
  2. An employee who knows the most used types of health economic models.
  3. An employee who understands what an ICER is.
  4. An employee who knows what a QALY is and how it is calculated.
  5. An employee who knows how to manage uncertainty in health economic models.

Course calendar

28 Nov 2022 9:00-16:00
  • The rationale behind the use of health economic analyses in Denmark.
  • Introduction to ICER, QALY, and costs.
  • What are the experiences to date since launching QALY in the Danish Medicines Council?
  • Introduction to the most used types of health economic models.
  • How to manage uncertainty in the health economic models.
Practical information

Related exams

Registration

Registration deadline
14 Nov 2022
Atrium
Lersø Parkallé 101
2100 København Ø
Register
28 Nov
Sometimes things change. This is the expected programme.

Course information

Examination

There is no examination for this course.

Course leader(s)

Anne Kolbye
Value Demonstration Manager
Roche A/S
Signe Thybo
Senior Manager, Nordic Value, HTA & HEOR
Bristol-Myers Squibb

Lecturer(s)

Anne Kolbye
Value Demonstration Manager
Roche A/S
Signe Thybo
Senior Manager, Nordic Value, HTA & HEOR
Bristol-Myers Squibb

You may also be interested in these courses

Want to know more, or need help?

Contact Client Manager Ida Salicath at +45 39 15 09 46